Anupam Chandra

Dr. Anupam Chandra


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Transplantation
Verified
Journal Article
Open access
ACAnupam Chandra
Anupam Chandra
KMKarsten Midtvedt
Karsten Midtvedt
AÅAnders Åsberg
Anders Åsberg
IEIvar Anders Eide
Ivar Anders Eide
Following successful kidney transplantation, recipients usually regain fertility. Post-engraftment pregnancies should be planned and the teratogenic mycophenolic acid should be replaced with azathioprine before conception. To avoid unintentional pregnancies, pre-conception counseling is mandatory in women of reproductive age who are scheduled for a kidney transplant. Counseling should be repeated after transplantation. Female recipients should receive advice to use long-acting reversible contraception and avoid pregnancy for a minimum of 1 year following transplantation. Conception should be deferred even longer in female recipients with moderate to severe proteinuria, uncontrolled hypertension or reduced graft function and be very carefully discussed in highly HLA-sensitized patients. The recipient wishes, values and acceptance of pregnancy-related risk should receive attention. Assisted fertilization increases the risk of pre-eclampsia, but still result in live births. Pregnancy management in kidney transplant recipients should be provided by a multidisciplinary team consisting of a nephrologist, a midwife and an obstetrician with expertise in high-risk pregnancies. Until measurement of unbound fraction of calcineurin inhibitors becomes clinically available, we recommend to adjust calcineurin inhibitor dose according to whole blood trough level, even though it overestimates the effective drug concentration during pregnancy. If nephrotoxicity is suspected, the calcineurin inhibitor dose should be reduced. Breastfeeding should be accepted after kidney transplantation since infant immunosuppressive drug exposure via breastmilk is extremely low. The prevalence of congenital malformations in children fathered by male recipients, including patients on mycophenolic acid therapy at the time of conception, is at level with the general population.

14 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
ACAnupam Chandra
Anupam Chandra
MLMagnus Nakrem Lyngbakken
Magnus Nakrem Lyngbakken
IEIvar Anders Eide
Ivar Anders Eide
HRHelge Røsjø
Helge Røsjø
TVThea Vigen
Thea Vigen
MSMy Svensson
My Svensson
Intake of industrially produced trans fatty acids (iTFAs) has previously been associated with dyslipidemia, insulin resistance, hypertension and inflammation, as well as increased cardiovascular (CV) morbidity and mortality. iTFA intake declined in Norway after the introduction of legislative bans against iTFA consumption. However, the relationship between the current iTFA intake and CV health is unclear. The aim of the present study was to investigate the association between current iTFA intake, reflected by plasma iTFA levels, and established CV risk factors. We also examined the associations between plasma ruminant TFA levels and CV risk factors. In this cross-sectional study, we included 3706 participants from a Norwegian general population, born in 1950 and residing in Akershus County, Norway. The statistical method was multivariable linear regression. Plasma iTFA levels were inversely associated with serum triglycerides (p < 0.001), fasting plasma glucose (p < 0.001), body mass index (p < 0.001), systolic and diastolic blood pressure (p = 0.001 and p = 0.03) and C-reactive protein (p = 0.001). Furthermore, high plasma iTFA levels were associated with higher education and less smoking and alcohol consumption. We found that plasma ruminant trans fatty acids (rTFA) levels were favorably associated with CV risk factors. Furthermore, plasma iTFA levels were inversely associated with CV risk factors. However, our results might have been driven by lifestyle factors. Overall, our findings suggest that the current low intake of iTFAs in Norway does not constitute a threat to CV health.

27 April 2020 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
ACAnupam Chandra
Anupam Chandra
HRHelge Røsjø
Helge Røsjø
MSMy Svensson
My Svensson
TVThea Vigen
Thea Vigen
HIHåkon Ihle-Hansen
Håkon Ihle-Hansen
IEIvar Anders Eide
Ivar Anders Eide

23 May 2019 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
ACAnupam Chandra
Anupam Chandra
HRHelge Røsjø
Helge Røsjø
IEIvar Anders Eide
Ivar Anders Eide
TVThea Vigen
Thea Vigen
HIHåkon Ihle-Hansen
Håkon Ihle-Hansen
MSMy Svensson
My Svensson